encepp

Budget impact analysis of discontinuing Tyrosin Kinase Inhibitors in patients with chronic myeloid leukemia achieving a complete molecular response by using probabilistic Markov approach (ECOSTIM)

21/04/2017
24/07/2024
EU PAS number:
EUPAS18568
Study
Finalised
Documents
Study protocol
Initial protocol
English (912.24 KB - PDF) View document
Study results
Study results
English (497.04 KB - PDF) View document
Study report
Other information
Publications
ENCePP Seal
This study has been awarded the ENCePP seal
Conflicts of interest of investigators
English (107.13 KB - PDF) View document
Composition of steering group and observers
English (176.06 KB - PDF) View document
Signed code of conduct
English (14.94 KB - PDF) View document
Signed code of conduct checklist
English (14.94 KB - PDF) View document
Signed checklist for study protocols
English (234.4 KB - PDF) View document